Order Entry
United States
ContactUsLinkComponent
StemSpan™ SFEM Medium
StemSpan™ SFEM Medium
Catalog # MSPP-09650
CAS Number:  
undefined
StemSpan™ SFEM Medium
Catalog # MSPP-09650
Supplier Number:  09650
CAS Number:  

Specifications

  • Description:
    StemSpan™ SFEM
  • Size:
    500 ml
  • Cat. No.:
    MSPP-09650
  • Supplier no.:
    9650

Specifications

About this item

Serum-free medium for culture and expansion of hematopoietic cells.

StemSpan™ serum-free expansion medium (SFEM) has been developed and tested for the in vitro culture and expansion of human hematopoietic cells, when the appropriate growth factors and supplements are added. This allows users the flexibility to prepare medium that meets their requirements. When combined with the appropriate cytokines, SFEM has been used for the culture and expansion of hematopoietic cells isolated from other species, including mouse, non-human primate, and dog. SFEM has also been used for culture of various other hematopoietic and non-hematopoietic cell types. Using appropriate StemSpan™ expansion supplements, SFEM may be used to expand CD34+ cells isolated from human cord blood, mobilized peripheral blood, or bone marrow samples, or to expand and differentiate lineage-committed progenitors to generate populations of erythroid, myeloid, or megakaryocyte progenitor cells. StemSpan™ SFEM II is an improved version of StemSpan™ SFEM that is further enriched to promote and support higher rates of CD34+ expansion and/or cell differentiation.

Caution: Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').